Tag: Upadacitinib
Upadacitinib Phase 3 Trials Identify Psychological and Functional Benefits of Ambitious Treatment Targets in AD Dermatology Times Source link
The state of dermatology drug development has been accelerating at an unprecedented rate for the last half-decade, with a myriad of targeted and novel therapy breakthroughs achieved in both common chronic diseases—like atopic dermatitis and psoriasis—and previously under-treated and psychosocially-affecting skin disorders—like alopecia areata and vitiligo. Drug options are becoming more robust, more versatile, and […]
March 17, 2022 2 min read Source/Disclosures Published by: Disclosures: Simpson reports financial relationship with AbbVie, Amgen, Arcutis, Arena Pharmaceuticals, Aslan Pharma, Boston Consulting Group, Collective Acumen, Corevita, Dermira, Eli Lilly, Evidera, Excerpta Medica, Forte Bio RX, Galderma, GlaxoSmithKline, Incyte, Janssen, Kyowa Hakko Kirin, LEO Pharmaceuticals, Medscape LLC, Merck, Novartis, Pfizer, Physicians […]